Cardiac Rhythm News

May 11, 2020 | Cardiac Rhythm News
COVID-19: Anticoagulants may improve survival among hospitalised COVID patients

Corresponding author Valentin Fuster (Mount Sinai Heart, New York, USA) and colleagues report in the Journal of the American College of Cardiology that hospitalised COVID-19 patients treated with anticoagulants had improved outcomes both in and out of the intensive care unit setting.

Apr 30, 2020 | Cardiac Rhythm News
Same-day discharge “feasible for majority of AF ablation patients”

Same-day discharge after atrial fibrillation (AF) ablation is feasible for the majority of patients when a standardised protocol is used, findings of a multicentre cohort study, published in the Journal of the American College of Cardiology (JACC), suggest.

Apr 17, 2020 | Cardiac Rhythm News
COVID-19: Testing for high-sensitivity cardiac troponin would be beneficial not a hindrance

In response to a recent American College of Cardiology (ACC) review that advocated that troponin should only be measured when a diagnosis of acute myocardial infarction is being considered, Andrew R Chapman (BHF Centre for Cardiovascular Science, Royal Infirmary of Edinburgh, Edinburgh, UK) and colleagues argue in Circulation that high-sensitivity cardiac troponin “could actually be an ally in the […]

Apr 6, 2020 | Cardiac Rhythm News
Decreased ACE2 levels found in ageing and cardiovascular disease can increase likelihood of severe COVID-19

The reduced levels of angiotensin converting enzyme (ACE) 2 associated with cardiovascular disease and increasing age lead to a higher susceptibility to greater disease severity in COVID-19.

Mar 20, 2020 | Cardiac Rhythm News
FDA issues new policy on remote monitoring devices for use during COVID-19 pandemic

The US Food and Drug Administration (FDA) has issued an immediately-in-effect guidance that allows manufacturers of certain FDA-cleared non-invasive, vital-sign-measuring devices to expand their use so that health care providers can use them to monitor patients remotely.

Mar 12, 2020 | Cardiac Rhythm News
Leadless pacing shows high rate of success at six months

Almost 70% of patients treated with a leadless left ventricular (LV) endocardial pacing system had a favourable clinical response at six months, a post-market surveillance registry has shown.Almost 70% of patients treated with a leadless left ventricular (LV) endocardial pacing system had a favourable clinical response at six months, a post-market surveillance registry has shown.

Feb 24, 2020 | Cardiac Rhythm News
Append Medical shares clinical proof-of-concept results for internal sealing of LAA

Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device to minimise stroke risk in atrial fibrillation (AF) patients, and Sheba Medical Center (Ramat Gan, Israel), have announced the clinical proof-of-concept data evaluating the safety of LAA closure through Append’s patented tissue manipulation procedure.

X